Clinical Trial Update: Safety and Efficacy Study Using Bevacizumab, Capecitabine and Oxaliplatin for Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase II trial evaluating the safety and efficacy of a bevacizumab-capecitabine-oxaliplatin combination for colorectal cancer has completed with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: University of Pittsburgh | Conditions: Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-07-12